Advertisement
Screener

BIOCLINICA INC Stock-Based Compensation

BIOCLINICA INC Stock-Based Compensation

BIOCLINICA INC reported Stock-Based Compensation of $1.85 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-02-22.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2013-02-22

  • BIOCLINICA INC share-based payment arrangement, noncash expense for the quarter ending 2012-12-31 was $479.00K, a 36.86% increase year-over-year.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $477.00K, a 37.46% increase year-over-year.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for the quarter ending 2012-06-30 was $466.00K, a 40.79% increase year-over-year.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for the quarter ending 2012-03-31 was $424.00K, a 24.34% increase year-over-year.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for fiscal 2012 was $1.85M, a 34.84% increase from fiscal 2011.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for fiscal 2011 was $1.37M, a 26.76% increase from fiscal 2010.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for fiscal 2010 was $1.08M, a 42.11% increase from fiscal 2009.
  • BIOCLINICA INC share-based payment arrangement, noncash expense for fiscal 2009 was $760.00K.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2012-12-31$479.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$956.00K
derived: sum of 2 quarters · filed 2013-02-22
$1.42M
derived: sum of 3 quarters · filed 2013-02-22
$1.85M
10-K · filed 2013-02-22
2012-09-30$477.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$943.00K
derived: sum of 2 quarters · filed 2012-11-09
$1.37M
10-Q · filed 2012-11-09
$1.72M
derived: sum of 4 quarters · filed 2013-02-22
2012-06-30$466.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$890.00K
10-Q · filed 2012-08-09
$1.24M
derived: sum of 3 quarters · filed 2013-02-22
$1.59M
derived: sum of 4 quarters · filed 2013-02-22
2012-03-31$424.00K
10-Q · filed 2012-05-10
$774.00K
derived: sum of 2 quarters · filed 2013-02-22
$1.12M
derived: sum of 3 quarters · filed 2013-02-22
$1.45M
derived: sum of 4 quarters · filed 2013-02-22
2011-12-31$350.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$697.00K
derived: sum of 2 quarters · filed 2013-02-22
$1.03M
derived: sum of 3 quarters · filed 2013-02-22
$1.37M
10-K · filed 2013-02-22
2011-09-30$347.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$678.00K
derived: sum of 2 quarters · filed 2012-11-09
$1.02M
10-Q · filed 2012-11-09
$1.31M
derived: sum of 4 quarters · filed 2013-02-22
2011-06-30$331.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$672.00K
10-Q · filed 2012-08-09
$961.00K
derived: sum of 3 quarters · filed 2013-02-22
$1.23M
derived: sum of 4 quarters · filed 2013-02-22
2011-03-31$341.00K
10-Q · filed 2012-05-10
$630.00K
derived: sum of 2 quarters · filed 2013-02-22
$902.00K
derived: sum of 3 quarters · filed 2013-02-22
2010-12-31$289.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22
$561.00K
derived: sum of 2 quarters · filed 2013-02-22
$1.08M
10-K · filed 2013-02-22
2010-09-30$272.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$791.00K
10-Q · filed 2011-11-14
2010-06-30$519.00K
10-Q · filed 2011-08-08
2009-12-31$760.00K
10-K · filed 2012-02-27